Ultrasonography as a tool for monitoring the development and progression of cholangiocarcinoma in opisthorchis viverrini/dimethylnitrosamine-induced hamsters

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 1, 2012, Pages 87-90

  Plengsuriyakarn, Tullayakorn ^a   Eursitthichai, Veerachai ^a   Labbunruang, Nipawan ^a   Na Bangchang, Kesara ^a   Tesana, Smarn ^b   Aumarm, Waraporn ^c   Pongpradit, Ananya ^c   Viyanant, Vithoon ^a  

^a THAMMASAT UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c KASETSART UNIVERSITY   (Thailand)

Author keywords

Cholangiocarcinoma; Diagnosis; Dimethylnitrosamine; Hamster; Opisthorchis viverrini; Ultrasonography

Indexed keywords

DIMETHYLNITROSAMINE;

ANIMAL; ARTICLE; BILE DUCT; BILE DUCT CARCINOMA; BILE DUCT TUMOR; COMPARATIVE STUDY; DISEASE COURSE; DRUG EFFECT; ECHOGRAPHY; FEMALE; HAMSTER; INTRAHEPATIC BILE DUCT; LIVER; MALE; OPISTHORCHIASIS; OPISTHORCHIS; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; PROGNOSIS; SYRIAN HAMSTER;

ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CRICETINAE; DIMETHYLNITROSAMINE; DISEASE PROGRESSION; FEMALE; LIVER; MALE; MESOCRICETUS; OPISTHORCHIASIS; OPISTHORCHIS; PROGNOSIS;

EID: 84864877629     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.1.087     Document Type: Article

References (30)

1. Bhamarapravati N, Thamavit W (1978). Animal studies on liver fluke infestation, dimethylnitrosamine, and bile duct carcinoma. Lancet, 1, 206-7.
2. Bjornsson E, Kilander A, Olsson R (1999). CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver, 19, 501-8.
3. Bloom CM, Langer B, Wilson SR (1999). Role of US in the detection, characterization, and staging of cholangiocarcinoma. Radiographics, 19, 1199-218.
4. Chaimuangraj S, Thamavit W, Tsuda H, Moore MA (2003). Experimental investigation of opisthorchiasis-associated cholangiocarcinoma induction in the Syrian hamster - pointers for control of the human disease. Asian Pac J Cancer Prev, 4, 87-93.
5. Choi JY, Kim MJ, Lee JM, et al (2008). Hilar cholangiocarcinoma: role of preoperative imaging with sonography, MDCT, MRI, and direct cholangiography. AJR Am J Roentgenol, 191, 1448-57.
6. Colli A, Cocciolo M, Mumoli N, et al (1998). Peripheral intrahepatic cholangiocarcinoma: ultrasound findings and differential diagnosis from hepatocellular carcinoma. Eur J Ultrasound, 7, 93-9.
7. Fava G, Lorenzini I (2012). Molecular pathogenesis of cholangiocarcinoma. Int J Hepatol, ?, ?-?.
8. Freeny PC (1999). Computed tomography in the diagnosis and staging of cholangiocarcinoma and pancreatic carcinoma. Ann Oncol, 10, 12-7.
9. Karstrup S (1988). Ultrasound diagnosis of cholangiocarcinoma at the confluence of the hepatic ducts (Klatskin tumours). Br J Radiol, 61, 987-90.
10. Mairiang E, Elkins DB, Mairiang P, et al (1992). Relationship between intensity of Opisthorchis viverrini infection and hepatobiliary disease detected by ultrasonography. J Gastroenterol Hepatol, 7, 17-21.
11. Mairiang E, Laha T, Bethony JM, et al (2011). Ultrasonography assessment of hepatobiliary abnormalities in 3359 subjects with Opisthorchis viverrini infection in endemic areas of Thailand. Parasitol Int, ?, ?-?.
12. Manfredi R, Barbaro B, Masselli G, Vecchioli A, Marano P (2004). Magnetic resonance imaging of cholangiocarcinoma. Semin Liver Dis, 24, 155-64.
13. Minami Y, Kudo M (2010). Hepatic malignancies: Correlation between sonographic findings and pathological features. World J Radiol, 2, 249-56.
14. Nakamura K, Takagi S, Sasaki N, et al (2010). Contrast-enhanced ultrasonography for characterization of canine focal liver lesions. Vet Radiol Ultrasound, 51, 79-85.
15. Nesbit GM, Johnson CD, James EM, et al (1988). Cholangiocarcinoma: diagnosis and evaluation of resectability by CT and sonography as procedures complementary to cholangiography. AJR Am J Roentgenol, 151, 933-8.
16. Pairojkul C, Shirai T, Hirohashi S, et al (1991). Multistage carcinogenesis of liver-fluke-associated cholangiocarcinoma in Thailand. Princess Takamatsu Symp, 22, 77-86.
17. Ramage JK, Donaghy A, Farrant JM, Iorns R, Williams R (1995). Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology, 108, 865-9.
18. Silsirivanit A, Araki N, Wongkham C, et al (2011). A novel serum carbohydrate marker on mucin 5AC: values for diagnostic and prognostic indicators for cholangiocarcinoma. Cancer, 117, 3393-403.
19. Sinakos E, Saenger AK, Keach J, Kim WR, Lindor KD (2011). Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma. Clin Gastroenterol Hepatol, 9, 434-9.
20. Sripa B, Kaewkes S (2002). Gall bladder and extrahepatic bile duct changes in Opisthorchis viverrini-infected hamsters. Acta Trop, 83, 29-36.
21. Sripa B, Bethony JM, Sithithaworn P, et al (2011). Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos. Acta Trop, 120, 158-68.
22. Sripa B, Kaewkes S, Sithithaworn P (2007). Liver fluke induces cholangiocarcinoma. PLoS Med, 4, 201.
23. Tao LY, Cai L, He XD, Liu W, Qu Q (2010). Comparison of serum tumor markers for intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Am Surg, 76, 1210-3.
24. Thamavit W, Bhamarapravati N, Sahaphong S, Vajrasthira S, Angsubhakorn S (1978). Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters. Cancer Res, 38, 4634-9.
25. Tillich M, Mischinger HJ, Preisegger KH, Rabl H, Szolar DH (1998). Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma. AJR Am J Roentgenol, 171, 651-8.
26. Ustundag Y, Bayraktar Y (2008). Cholangiocarcinoma: a compact review of the literature. World J Gastroenterol, 14, 6458-66.
27. Vanderveen KA, Hussain HK (2004). Magnetic resonance imaging of cholangiocarcinoma. Cancer Imaging, 4, 104-15.
28. Xu H, et al. 2008. Elevation of serum KL-6 mucin levels in patients with cholangiocarcinoma. Hepatogastroenterology, 55, 2000-4.
29. Yasutake M, Sasaki H, Fujimatsu M, et al (1988). Metastatic cholangiocarcinoma to the right atrial appendage detected by magnetic resonance imaging. Am Heart J, 116, 566-8.
30. Zografos GN, Farfaras A, Zagouri F, Chrysikos D, Karaliotas K, (2011). Cholangiocarcinoma: principles and current trends. Hepatobiliary Pancreat Dis Int, 10, 10-20.